Coenzyme Q10 (CoQ10) or ubiquinone is a well-known component of the mitochondrial respiratory chain. In humans, CoQ10 deficiency causes a mitochondrial syndrome with an unexplained variability in the clinical presentations. To try to understand this heterogeneity in the clinical phenotypes, we have generated a Coq9 Knockin (R239X) mouse model. The lack of a functional Coq9 protein in homozygous Coq9 mutant (Coq9X/X) mice causes a severe reduction in the Coq7 protein and, as consequence, a widespread CoQ deficiency and accumulation of demethoxyubiquinone. The deficit in CoQ induces a brain-specific impairment of mitochondrial bioenergetics performance, a reduction in respiratory control ratio, ATP levels and ATP/ADP ratio and specific loss of respiratory complex I. These effects lead to neuronal death and demyelinization with severe vacuolization and astrogliosis in the brain of Coq9X/Xmice that consequently die between 3 and 6 months of age. These results suggest that the instability of mitochondrial complex I in the brain, as a primary event, triggers the development of mitochondrial encephalomyopathy associated with CoQ deficiency. © The Author 2012. Published by Oxford University Press. All rights reserved.
CITATION STYLE
García-Corzo, L., Luna-Sánchez, M., Doerrier, C., García, J. A., Guarás, A., Acín-Pérez, R., … López, L. C. (2013). Dysfunctional coq9 protein causes predominant encephalomyopathy associated with CoQ deficiency. Human Molecular Genetics, 22(6), 1233–1248. https://doi.org/10.1093/hmg/dds530
Mendeley helps you to discover research relevant for your work.